首页 | 本学科首页   官方微博 | 高级检索  
检索        

柳氮磺吡啶结肠溶胶囊联合云南白药治疗溃疡性结肠炎
引用本文:杜坤庭,葛勤利,杨伟捷,万顺梅.柳氮磺吡啶结肠溶胶囊联合云南白药治疗溃疡性结肠炎[J].中国基层医药,2011,18(18):2465-2466.
作者姓名:杜坤庭  葛勤利  杨伟捷  万顺梅
作者单位:解放军第一医院消化科,甘肃省兰州,730030
摘    要:目的观察柳氮磺毗啶结肠溶胶囊联合云南白药治疗轻、中度溃疡性结肠炎的临床疗效。方法选取轻、中度溃疡性结肠炎患者60例,随机分为治疗组与对照组各30例。治疗组口服柳氮磺毗啶结肠溶胶囊及云南白药,对照组仅口服柳氮磺吡啶结肠溶胶囊。结果治疗组总有效率为90.0%,临床治愈率为73.3%;对照组总有效率为66.7%,临床治愈率为43.3%,两组差异均有统计学意义(均P〈0.05)。结论柳氮磺吡啶结肠溶胶囊联合云南白药治疗治疗轻、中度溃疡性结炎具有较好的临床疗效。

关 键 词:结肠炎  溃疡性  柳氮磺毗啶  云南白药

Clinical effect of sulfasalazine capsulae enterosolubilis with Yunnanbaiyao for ulcerative colitis
DU Kun-ting,GE Qin-li,YANG Wei-jie,WAN Shun-mei.Clinical effect of sulfasalazine capsulae enterosolubilis with Yunnanbaiyao for ulcerative colitis[J].Chinese Journal of Primary Medicine and Pharmacy,2011,18(18):2465-2466.
Authors:DU Kun-ting  GE Qin-li  YANG Wei-jie  WAN Shun-mei
Institution:DU Kun-ting, GE Qin-li , YANG Wei-jie , IVAN Shun-mei. Department of Gastroenterology, The First Hospital of PLA , Lanzhou , Gansu 730030, China
Abstract:Objective To evaluate the clinical effect of sulfasalazine capsulae enterosolubilis with Yunnanbaiyao for ulcerative colitis. Methods Sixty patients with ulcerative colitis were randomly divided into two groups,thirty cases in treatment group and thirty cases in control group. Patients in treatment group received sulfasalazine capsulae enterosolubilis with Ytmnanbaiyao orally,patients in control group were given sulfasalazine capsulae enterosolubilis orally only. Results The total effective rate of treatment group was 90. 0% ,clinical recovery rate was 73.3% ;The total effective rate of control group was 66.7% ,clinical recovery rate was 43.3% ,the differences was statistically significant(P <0.05). Conclusion The clinical effect of sulfasalazine capsulae enterosolubilis with Yunnanbaiyao for ulcerative colitis was good,and should be used furthedy.
Keywords:Colitis  ulcerative  Sulfasalazine  Yunnanbaiyao
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号